Long-term prognosis of juvenile myoclonic epilepsy: A systematic review searching for sex differences

[1]  B. Mostacci,et al.  Alternatives to valproate in girls and women of childbearing potential with Idiopathic Generalized Epilepsies: state of the art and guidance for the clinician proposed by the Epilepsy and Gender Commission of the Italian League Against Epilepsy (LICE) , 2020, Seizure.

[2]  M. Manfredi,et al.  Valproate impact and sex-dependent seizure remission in patients with idiopathic generalized epilepsy , 2020, Journal of the Neurological Sciences.

[3]  E. Beghi.  The Epidemiology of Epilepsy , 2019, Neuroepidemiology.

[4]  M. Manfredi,et al.  Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome , 2019, Epilepsia.

[5]  J. F. Zapata Berruecos,et al.  [Clinical and psychosocial factors associated with seizure control in patients with juvenile myoclonic epilepsy]. , 2019, Revista de neurología (Ed. impresa).

[6]  R. Alizadeh-Navaei,et al.  Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial , 2019, Epilepsy Research.

[7]  S. Johannessen,et al.  Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy , 2019, Epilepsy & Behavior.

[8]  S. Johannessen,et al.  Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy , 2019, Epilepsy Research.

[9]  C. Özkara,et al.  Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy , 2019, Seizure.

[10]  M. Zappia,et al.  Eyelid myoclonia with absences: Electroclinical features and prognostic factors , 2019, Epilepsia.

[11]  Dong Zhou,et al.  Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients , 2019, Epilepsia open.

[12]  M. Syvertsen,et al.  Antiepileptic drug withdrawal in juvenile myoclonic epilepsy , 2018, Acta neurologica Scandinavica.

[13]  L. Guilhoto,et al.  Prognosis of Juvenile myoclonic epilepsy with eye-closure sensitivity , 2018, Seizure.

[14]  Josemir W Sander,et al.  Refractory juvenile myoclonic epilepsy: a meta‐analysis of prevalence and risk factors , 2018, European journal of neurology.

[15]  Josemir W Sander,et al.  Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center , 2018, Epilepsy & Behavior.

[16]  E. Brodtkorb,et al.  Prolonged epileptiform EEG runs are associated with persistent seizures in juvenile myoclonic epilepsy , 2017, Epilepsy Research.

[17]  A. M. D. Silva,et al.  Photosensitivity and epilepsy: Current concepts and perspectives—A narrative review , 2017, Seizure.

[18]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[19]  M. Brodie,et al.  Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate , 2016, Epilepsy Research.

[20]  P. Wolf,et al.  Phenotyping juvenile myoclonic epilepsy. Praxis induction as a biomarker of unfavorable prognosis , 2015, Seizure.

[21]  T. Tomson,et al.  Dose-dependent teratogenicity of valproate in mono- and polytherapy , 2015, Neurology.

[22]  A. Asadi-Pooya,et al.  Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME) , 2014, Seizure.

[23]  N. Jović,et al.  Terminal remission is possible in some patients with juvenile myoclonic epilepsy without therapy. , 2014, Medicinski pregled.

[24]  J. Engel,et al.  Structural and functional correlates of epileptogenesis — Does gender matter? , 2014, Neurobiology of Disease.

[25]  E. Brodtkorb,et al.  Clinical heterogeneity of juvenile myoclonic epilepsy: Follow-up after an interval of more than 20 years , 2014, Seizure.

[26]  B. Schmitz,et al.  Prognosis of juvenile myoclonic epilepsy 45 years after onset , 2013, Neurology.

[27]  N. Bebek,et al.  Eye closure sensitivity in juvenile myoclonic epilepsy and its effect on prognosis , 2013, Seizure.

[28]  A. Crespel,et al.  Management of juvenile myoclonic epilepsy , 2013, Epilepsy & Behavior.

[29]  P. Camfield,et al.  Lifetime prognosis of juvenile myoclonic epilepsy , 2013, Epilepsy & Behavior.

[30]  P. Striano,et al.  Epidemiology of juvenile myoclonic epilepsy , 2013, Epilepsy & Behavior.

[31]  C. Bombardier,et al.  Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.

[32]  C. Kessler,et al.  Predictors for long‐term seizure outcome in juvenile myoclonic epilepsy: 25–63 years of follow‐up , 2012, Epilepsia.

[33]  T. Pekmezović,et al.  Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy , 2011, Seizure.

[34]  John S. Duncan,et al.  Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study , 2011, Brain : a journal of neurology.

[35]  Kátia Lin,et al.  Prognosis of juvenile myoclonic epilepsy is related to endophenotypes , 2011, Seizure.

[36]  R. Sekuler,et al.  Sex differences in the acquisition of complex skilled movements , 2010, Experimental Brain Research.

[37]  M. Shevell,et al.  A Profile of Adolescent-Onset Epilepsy , 2009, Journal of child neurology.

[38]  C. Gurses,et al.  Myoclonic seizures subside in the fourth decade in juvenile myoclonic epilepsy , 2008, Neurology.

[39]  M. Brodie,et al.  Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non‐pediatric setting , 2007, Acta neurologica Scandinavica.

[40]  S. Moshé,et al.  Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy , 2006, Brain and Development.

[41]  Per Sidenius,et al.  Gender Differences in Epilepsy , 2005, Epilepsia.

[42]  E. K. Louis,et al.  Pattern‐sensitive Epilepsy: Electroclinical Characteristics, Natural History, and Delineation of the Epileptic Syndrome , 2005, Epilepsia.

[43]  P. Genton,et al.  Clinical factors of drug resistance in juvenile myoclonic epilepsy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[44]  B. Engelsen,et al.  Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients , 1998, Seizure.

[45]  C. Panayiotopoulos,et al.  Juvenile Myoclonic Epilepsy: A 5‐Year Prospective Study , 1994, Epilepsia.

[46]  R. Mai,et al.  Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients , 1992, Seizure.

[47]  H. Matsuoka.  The Seizure Prognosis of Juvenile Myoclonic Epilepsy , 1992, The Japanese journal of psychiatry and neurology.

[48]  J. Dean,et al.  Juvenile Myoclonic Epilepsy: Long‐Term Response to Therapy , 1989, Epilepsia.

[49]  T. Kurashige,et al.  Proposal for Revised Classification of Epilepsies and Epileptic Syndromes , 1989, No to hattatsu = Brain and development.

[50]  N. Demirkaya,et al.  Clinical and EEG Analysis of Patients With Idiopathic Generalized Epilepsy and Photosensitivity , 2009 .

[51]  A. Sundqvist.  Juvenile myoclonic epilepsy: Events before diagnosis , 1990 .

[52]  D. Janz,et al.  Juvenile myoclonic epilepsy. Epilepsy with impulsive petit mal. , 1989, Cleveland Clinic journal of medicine.